Authors:
Le, VD
Mak, CC
Lin, YC
Elder, JH
Wong, CH
Citation: Vd. Le et al., Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine, BIO MED CH, 9(5), 2001, pp. 1185-1195
Authors:
Mak, CC
Le, VD
Lin, YC
Elder, JH
Wong, CH
Citation: Cc. Mak et al., Design, synthesis, and biological evaluation of HIV/FIV protease inhibitors incorporating a conformationally constrained macrocycle with a small P3 'residue, BIOORG MED, 11(2), 2001, pp. 219-222
Authors:
Lin, YC
Beck, Z
Lee, T
Le, VD
Morris, GM
Olson, AJ
Wong, CH
Elder, JH
Citation: Yc. Lin et al., Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease, J VIROLOGY, 74(10), 2000, pp. 4710-4720
Citation: Vd. Le et Ch. Wong, Synthesis of 2-substituted polyhydroxytetrahydropyrimidines (N-hydroxy cyclic guanidino-sugars): Transition state mimics of enzymatic glycosidic cleavage, J ORG CHEM, 65(8), 2000, pp. 2399-2409
Citation: Pj. Dudfield et al., Synthesis of C-ribosyl imidazo[2,1-f][1,2,4]triazines as inhibitors of adenosine and AMP deaminases, J CHEM S P1, (20), 1999, pp. 2929-2936
Citation: Pj. Dudfield et al., Synthesis of C-ribosyl 1,2,4-triazolo[3,4-f][1,2,4]triazines as inhibitorsof adenosine and AMP deaminases, J CHEM S P1, (20), 1999, pp. 2937-2942
Authors:
Lee, TY
Le, VD
Lim, DY
Lin, YC
Morris, GM
Wong, AL
Olson, AJ
Elder, JH
Wong, CH
Citation: Ty. Lee et al., Development of a new type of protease inhibitors, efficacious against FIV and HIV variants, J AM CHEM S, 121(6), 1999, pp. 1145-1155